Efficacy and Safety of Regorafenib Combined with Toripalimab in the Third-Line and beyond Treatment of Advanced Colorectal Cancer

BACKGROUND: The most effective treatment of immune checkpoint inhibitors (ICIs) is restricted in microsatellite instability (MSI-H) subsets of advanced colorectal cancer, but MSI-H only accounts for 4-5% among them. ICIs are completely ineffective in advanced colorectal cancer patients with microsat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wei, Tao, Qiaomeng, Zhang, Yufeng, Yi, Fengming, Feng, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486501/
https://www.ncbi.nlm.nih.gov/pubmed/34603452
http://dx.doi.org/10.1155/2021/9959946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486501/
https://www.ncbi.nlm.nih.gov/pubmed/34603452
http://dx.doi.org/10.1155/2021/9959946

Ejemplares similares